The Circulating Micro-RNAs (-122, -34a and -99a) as Predictive Biomarkers for Non-Alcoholic Fatty Liver Diseases.
Olfat M HendyHatem RabieAmr El FoulyMohammed E Abdel SameaNashwa AbdelmotelbAmr Aly ElshormilisyMahmoud AllamSamia Taher AliNessren Mohamed Bahaa El-DeenShimaa AbdelsattarSomia Mokabel MohamedPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2019)
The integration of a circulating mi-RNA panel to diagnose NAFLD cases and to discriminate between SS and NASH. Large-scale study is still needed to verify the other mi-RNA profiles and their role in NAFLD pathogenesis and targeting therapy.